| Entry |
|
| Name |
Mutation-inactivated VHL to HIF-1 signaling pathway
|
| Definition |
(VHL*+RBX1+ELOC+ELOB+CUL2) // HIF1A == ARNT => (SLC2A1,VEGFA,TGFB,PDGFB,TGFA) |
| Expanded |
(7428v2+9978+6921+6923+8453) // 3091 == 405 => (6513,7422,7040,7042,7043,5155,7039) |
| Class |
|
| Type |
Variant
|
| Pathway |
|
| Disease |
|
| Gene |
| 7428 | VHL; von Hippel-Lindau tumor suppressor |
| 3091 | HIF1A; hypoxia inducible factor 1 alpha subunit |
| 405 | ARNT; aryl hydrocarbon receptor nuclear translocator |
| 6513 | SLC2A1; solute carrier family 2 member 1 |
| 7422 | VEGFA; vascular endothelial growth factor A |
| 7040 | TGFB1; transforming growth factor beta 1 |
| 7042 | TGFB2; transforming growth factor beta 2 |
| 7043 | TGFB3; transforming growth factor beta 3 |
| 5155 | PDGFB; platelet derived growth factor subunit B |
| 7039 | TGFA; transforming growth factor alpha |
|
| Variant |
|
| Reference |
|
| Authors |
Cohen HT, McGovern FJ. |
| Title |
Renal-cell carcinoma. |
| Journal |
|
| Reference |
|
| Authors |
Pavlovich CP, Schmidt LS. |
| Title |
Searching for the hereditary causes of renal-cell carcinoma. |
| Journal |
|
| Reference |
|
| Authors |
Linehan WM, Srinivasan R, Schmidt LS |
| Title |
The genetic basis of kidney cancer: a metabolic disease. |
| Journal |
|
| LinkDB |
|